4
Changes in Ownership
BridgeBio Pharma, Inc. Filed Acc 0000899243-20-032507
Chief Business Officer sold 10,000 shares at an average $51.52 ($515,204)
- Chief Business Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HENDERSON MICHAEL THOMAS · Chief Business Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 1 in the form | +10,000 | $1.05 | $10,500 | 284,211 | D |
| 2020-12-01 | Sale : show line 2 in the form | −3,028 | $51.12 | $154,796 | 281,183 | D |
| 2020-12-01 | Sale : show line 3 in the form | −6,972 | $51.69 | $360,408 | 274,211 | D |
| Open-market sales · 10,000 sh · avg $51.52 · $515,204 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −10,000 | 8,282 | D |
Loading xslF345X03/doc4.xml…